NBE Therapeutics
SwitzerlandEntry
2013
Hold
7yr
Exit
2020
Who owns NBE Therapeutics?
NBE Therapeutics was owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage) from 2013 to 2020, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-07
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
Germany
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track NBE Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy NBE Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on NBE Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue